Flow cytometry has emerged as a key tool for exploratory research during drug discovery and development processes. It has the ability to analyze a large number of particles in a short period of time and to provide statistically robust information about the cell population. Flow cytometry method helps to subclassify cell types to decide on the best treatment plan. It can also detect residual levels of disease after treatment. The growing number of clinical trials and increasing focus on developing novel therapeutics to address the rising disease burden are expected to contribute to the growth of the flow cytometry market during the forecast period.
The development of advanced flow cytometry products has brought increased automation, ease of use, and more accurate analysis for various research and clinical uses. Also, the discoveries in stem cell biology have amplified the importance of pluripotent stem cells in therapeutics and have improved researchers’ understanding of normal and disease processes. The evolving pipeline for stem cell research is creating growth opportunities for players to develop effective flow cytometry methods with the ability to investigate large cell populations at the single-cell level in stem cell research.Meticulous Research® in its latest publication on flow cytometry market states that the global flow cytometry market is expected to grow at a CAGR of around 6.5% from 2019 to 2027 to exceed $4.1 billion by 2027.
The growth of the global flow cytometry market is mainly attributed to the rising global incidence and prevalence of chronic diseases, such as HIV-AIDS and cancer, increasing adoption of flow cytometry techniques in research and academia, and growing focus on immunology and immuno-oncology research. In addition, evolving pipeline for stem cell research and adoption of recombinant DNA technology for antibody production are further expected to provide significant opportunities for the various stakeholders in this market. However, high product costs are likely to hinder the market growth. On the other hand, inadequate research infrastructure across emerging countries and complexities related to development of the reagents for flow cytometry procedure are some of the key challenges for players in this market.
To provide efficient analysis, Meticulous Research® has segmented this market by Product & Solution (Consumables, Systems, Software, Service), by Technology (Cell & Bead Based), by Application (Research, Clinical, Industrial), End-user (Academic & Research Institute, Hospitals & Clinical Testing Labs, Pharmaceutical & Biotechnology Companies), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Request Exclusive Free Sample PDF Of This Report At:https://www.meticulousresearch.com/request-sample-report/cp_id=5067
Geographically, North America commanded the largest share of the global flow cytometry market in 2018, closely followed by the Europe, and Asia Pacific. However, Asia Pacific region is slated to register fastest growth during the forecast period primarily due to the increasing participation by China, India, Japan, and South Korea in flow cytometry-based research and increasing public-private initiatives undertaken to advance the research practices in this region.
Based on technology, the bead-based flow cytometry segment is expected to grow at the highest CAGR during the forecast period. This is mainly attributed to the procedural advantages offered by this technology over other cell-based technology (such as ELISA and western blot), including its capacity to detect multiple analytes, high reproducibility, stability, and speed.
Scope of the Report:
Flow Cytometry Market, by Technology
Cell-Based Flow Cytometry
Bead-Based Flow Cytometry
Flow Cytometry Market, by Product
Consumables and Accessories
Flow Cytometry Market, by Application
Research applicationsDrug Discovery
Stem Cell Research
Other Research Applications
Other Clinical Applications
Flow Cytometry Market, by End Users
Academic & Research Institutes
Hospitals & Clinical Testing Laboratories
Pharmaceutical & Biotechnology Companies
Other End Users
Flow Cytometry Market, by Geography
Rest of Europe (RoE)
Rest of APAC (RoAPAC)
Middle East & Africa
Ask For Discount (Special Offer: Get 25% discount on this report):https://www.meticulousresearch.com/request-discount/cp_id=5067
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (U.S.), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Cytonome/ST LLC (U.S.), Beckman Coulter, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).
Key questions answered in the report:
Increasing Adoption of Flow Cytometry Techniques in Research Areas in Emerging Economies Supports the Flow Cytometry Market Growth
Which are the emerging economies offer lucrative growth opportunities for flow cytometry market?
What factors to drive market growth in emerging economies?
How does the penetration of flow cytometry technology in developed regions differ from developing regions like Asia-Pacific and Latin America?
How is the competitive situation between global market leaders and prominent local players in this market?
Which are the market segments offer higher growth potential in terms of technology, product & solution, application, end, user, regions, and countries?
Bead-based Technology to Register Fastest Growth in Flow Cytometry Market
How is the bead-based technology have better acceptance as compared to the other technologies?
Which geographic segment is expected to register highest growth in the bead-based technology market?
What are the factors driving greater demand for bead-based flow cytometry services?
Flow Cytometry Market Favors both Regional and Local Manufacturers that Compete in Multiple Segments
How are the top market players and what strategies they adopt to gain majority of the market share?
What strategies should emerging/ developing companies look to enter/compete effectively in this market?
What are the strategies local players adopted to compete with the global market leaders?
What are the major drivers, restraints, and opportunities in the flow cytometry market?
Who are the major players in various countries and what share of the market do they hold?
What are the geographical trends and high growth regions/ countries?
Recent Developments Taken Place in the Flow Cytometry Market
What are the technological advancements have taken place in this industry?
Which companies are recently merged/acquired by prominent players in this market and how will these unions affect the competitive landscape of the flow cytometry market?
Who are the major players in the global flow cytometry market and what shares of the market do they hold?
What are the local emerging players in this market and how do they compete with the global players?
DOWNLOAD FREE REPORT SAMPLE HERE (USE OFFICIAL EMAIL ID TO GET HIGHER PRIORITY) @https://www.meticulousresearch.com/download-sample-report/cp_id=5067
Email- [email protected]
Contact Sales- +1-646-781-8004
This post was originally published on The Market Plan